[Advances in SARS-CoV-2 diagnostic strategies during the later COVID-19 era]

Zhonghua Jie He He Hu Xi Za Zhi. 2022 Aug 12;45(8):819-825. doi: 10.3760/cma.j.cn112147-20220326-00240.
[Article in Chinese]

Abstract

Based on natural infection or vaccination, the protective barrier for population has been preliminarily established. However, with constant appearances of SARS-CoV-2 variants, breakthrough infection events cannot be completely avoided, and thus the diagnostic strategy is still the key to discovering epidemic sources and blocking the transmission chain. Currently, SARS-CoV-2 diagnosis technologies based on nucleic acid, antigen and antibody detections have developed and extended in diversity. Under the background of work resumption and epidemic-prevention normalization during the later COVID-19 era, it is necessary for us to choose appropriate detection methods to satisfy the need of epidemic prevention and control in various scenarios. We summarized the principles and applicable characteristics of existing SARS-CoV-2 detection technologies in this paper, aimed to provide guidance for clinical and public health personnel to make targeted decisions.

尽管自然感染或疫苗接种已经初步建立了群体保护屏障,但随着多种新冠病毒变异体的持续出现,突破性感染仍然无法完全避免,新冠病毒检测仍是发现传染源和中断传播链的关键。目前,以核酸、抗原、抗体检测为基础的新冠病毒检测形式呈多元化发展。在相对疫情早期的后新冠时代,复工复产和疫情防控常态化,需要我们根据不同场景的防控需求选择合适的检测手段。本文总结了现有新冠病毒检测技术的原理及其适用特征,以期为临床及公共卫生人员提供精准化决策依据。.

MeSH terms

  • COVID-19 Testing
  • COVID-19* / diagnosis
  • Epidemics*
  • Humans
  • SARS-CoV-2

Supplementary concepts

  • SARS-CoV-2 variants